The effect of depression and health-related quality of life on the outcome of hemodialysis patients  by Jeon, Hee Jung et al.
Kidney Res Clin Pract 31 (2012) 54–61journal homepage: http://www.krcp-ksn.com
Kidney Research and Clinical Practice2211-91
license
http://d
☆Each
writing
collect
design
All a
n Corre
156-70
E-mailContents lists available at ScienceDirectOriginal ArticleThe effect of depression and health-related quality of life on the
outcome of hemodialysis patients$
Hee Jung Jeon 1, Hayne Cho Park 1, Ji In Park 1, Jung Pyo Lee 2, Kook-Hwan Oh 1,
Ho Jun Chin 3, Kwon Wook Joo 1, Yon Su Kim1, Chun Soo Lim 2, Curie Ahn 1, Jin Suk Han 1,
Suhnggwon Kim 1, Yun Kyu Oh 2,n1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
2 Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea
3 Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, KoreaArticle history:
Received 27 October 2011
Received in revised form
12 December 2011
Accepted 21 December 2011
Available online 25 January 2012
Keywords:
Depression
Hemodialysis
Outcome
Quality of life32/$ - see front matter & 2012. The Korea
(http://creativecommons.org/licenses/by-n
x.doi.org/10.1016/j.krcp.2012.01.001
author’s speciﬁc contributions to the w
of the paper. Hayne Cho Park, Ji In Park
ion, data analysis. Yon Su Kim, Chun Soo
, sample collection, data analysis, writin
uthors have never submitted the manu
sponding author. Department of Intern
7, Korea.
address: yoonkyu@snu.ac.kr (YK Oh).a b s t r a c t
Background: In hemodialysis (HD) patients, traditional risk factors cannot explain
all of the mortality and morbidity. This study was designed to investigate the effect
of depression and health-related quality of life (HRQOL) on prognosis in main-
tenance HD patients.
Methods: In February 2008, the Beck’s Depression Inventory and the Kidney
Dialysis Quality of Life—Short Form were utilized to measure depression and
HRQOL. Until February 2011, the mortality, cardiovascular events, infection, and
hospitalization were investigated, retrospectively.
Results: Among the 166 patients, the 3-year cumulative survival rate was 88.8%,
and the depression did not affect survival (depression vs. nondepression: 91.8% vs.
87.2%, P¼0.437). The upper tertiles in physical component summary (PCS) were
correlated with lower mortality (OR, 0.12; P¼0.05) and fewer cardiovascular events
(OR, 0.09; P¼0.024) than the lower tertiles. The upper tertiles in kidney disease
component summary (KDCS) were associated with less hospitalization than the
lower tertiles (OR, 0.38; P¼0.024). After adjusting for multiple variables including
age, comorbidity index, and albumin, upper tertiles in PCS were correlated with
fewer cardiovascular events than the lower tertiles (OR, 0.08; P¼0.038).
Conclusion: The cross-sectional survey of whether HD patients had depression was
not signiﬁcantly associated with mortality and morbidity. HRQOL was correlated
with mortality, cardiovascular events and hospitalization.
& 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).n Society of Nephrology. Published by Elsevier. This is an open access article under the CC BY-NC-ND
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In hemodialysis (HD) patients, traditional risk factors
including diabetes mellitus, atherosclerosis, and smoking,
signiﬁcantly worsen prognosis of patients; however, these
factors cannot explain all of the mortality and morbidities of
the HD patients. Depression is the most common psychological
problem among end-stage renal disease (ESRD) patients [1].
The health-related quality of life (HRQOL), which reﬂects
patients’ subjective “well-being”, as well as depression is
related to higher morbidity and mortality rates in HD patients
[2–4]. However, the studies about the effect of depression and
HRQOL on the HD patients’ mortality and morbidity in Korea
are scarce. The aim of this study was to investigate the effect of
depression and HRQOL on patients’ prognosis in maintenance
HD patients.Methods
Patients and methods
We have previously described the methods for evaluat-
ing depression and HRQOL of patients [5]. A total of 166 ESRD
patients on maintenance HD from three university hospitals
(Seoul National University Hospital, Seoul National University
Bundang Hospital, Seoul National University Boramae Hospi-
tal) and three local dialysis clinics in Seoul were included.
These participants had been on a HD program for more than
3 months before study recruitment. Exclusion criteria were
those patients who had started dialysis for acute kidney injury
or who had been on dialysis for less than 3 months. Patients
who refused to enroll were excluded from this study. We also
excluded patients who were diagnosed with dementia. Inter-
viewers read and checked the questionnaires for the patients
who had difﬁculty in reading and writing. The Beck’s depres-
sion Inventory (K-BDI) and the Korean version of Kidney
Dialysis Quality of Life—Short Form (KDQOL-SFTM) were uti-
lized to measure depression and HRQOL in maintenance HD
patients at February 2008. The BDI contains 21 self-reported
items which are rated on a scale of 0–3 points [6]. To deﬁne
moderate to severe depression as a depression group, we
established 18 as a cut-off value. Furthermore, The KDQOL-
SFTM 1.3 includes general 36 items compensated with 43
kidney-disease speciﬁc items and an overall health assessment
item for patients with chronic kidney disease (CKD). The
KDQOL-SFTM assesses physical component summary score
(PCS), mental component summary score (MCS), and kidney
disease component summary score (KDCS) [7]. The Korean
version of KDQOL-SFTM was recently translated and vali-
dated by Park et al [8]. Instruments and scoring programs of
KDQOL-SFTM 1.3 can be found at http://www.gim.med.ucla.
edu/kdqol/downloads/download.html.
In February 2008, demographic and laboratory ﬁndings
were gained from the patients’ self-reports and the med-
ical record. Age, gender, marital status, religion, economic
status, comorbidity (hypertension, diabetes mellitus, cor-
onary artery disease, cerebrovascular disease, peripheral arterydisease, malignancy), causes of ESRD, and duration of HD were
reviewed. Hemoglobin (Hb), plasma glucose, serum albumin,
blood urea nitrogen (BUN), and creatinine (Cr) were obtained
from laboratory data at the entry point of this study. To
quantify comorbidity, we utilized the modiﬁed Charlson
comorbidity index (MCCI). The MCCI has been frequently used
and validated in studies of HRQOL with ESRD patients [9].
From February 1, 2008 to February 28, 2011, we investigated
enrolled patients’ mortality, cardiovascular events, infection
and complications that required hospitalization through the
medical records, retrospectively. The cardiovascular events
were deﬁned as acute myocardial infarction, unstable angina
requiring coronary intervention or bypass graft, and cardiac
arrest. In addition, we analyzed the effect of depression and
HRQOL on the patients’ mortality and morbidity.
Statistical analysis
All analyses were performed using SPSS software (SPSS
version 18.0.0). The results were given as mean7standard
deviations (SD) for continuous variables and as proportions for
categorical variables. Analyses included simple means and
frequencies for baseline characteristics data, and unadjusted
Cox’s proportional hazard model was used to evaluate risk
factors for mortality. All subjects were divided into two groups
according to depression scores (BDI418, BDIr18), and into
three groups according to tertiles of KDQOL-SFTM scores. The
Kaplan–Meier method and the log rank test were used to
assess and compare cumulative mortality rates between
groups. The adjusted hazard ratios for all-cause mortality were
calculated by Cox’s proportional hazard model. Model 1 was
adjusted for age, comorbidity score and serum albumin.
Gender, duration of HD, Hb, glucose, marriage, religion and
economic status were added in Model 2. Finally, we performed
binary logistic regression analysis to determine the relation-
ship between depression and morbidity (cardiovascular
events, infection, and hospitalization) or tertiles of KDQOL-
SFTM scores and morbidity. A P value of less than 0.05 was
considered to be statistically signiﬁcant. The study protocol
was approved by the Institutional Review Board of Seoul
National University Hospital. Informed consent was conﬁrmed
by the institutional review board (IRB).Results
Baseline characteristics of patients
Table 1 shows the demographic, clinical and laboratory
data. Of the 166 patients, the mean age was 57.9714.0
years (range, 19–85 years). A total of 100 (60.2%) patients
were male and 66 (39.8%) were female. A total of 136
(81.9%) patients were married, 112 (67.5%) had religion, and
98 (59.0%) were in middle economic status. The mean
comorbidity score was 5.1972.82 (range, 0–12) and 33.7%
had diabetes mellitus. The most common cause of
ESRD was diabetes mellitus (30.1%), followed by hyper-
tension (19.3%) and glomerulonephritis (19.3%). The mean
Table 1. Baseline Characteristics and Odds Ratios for Mortality
Total subjects Mortality (unadjusted)
(n¼166) OR (95% CI) P
Age (yr), mean 57.9 (19–85) 10-year increase 1.83 (1.10–3.06) 0.021
Male gender (%) 100 (60.2%) (vs. female) 1.06 (0.39–2.93) 0.906
Marital status, married (%) 136 (81.9%) (vs. no) 1.69 (0.39–7.46) 0.486
Religion, yes (%) 112 (67.5%) (vs. no) 1.24 (0.43–3.57) 0.690
Economic status (%)
Low 39 (23.5%) 1 (reference)
Middle 98 (59.0%) 1.70 (0.36–8.02) 0.501
High 16 (9.6%) 1.17 (0.11–12.9) 0.896
Comorbidity (%)
HTN 129 (77.7%) (vs. no) 1.30 (0.37–4.55) 0.686
DM 56 (33.7%) (vs. no) 1.61 (0.60–4.32) 0.347
CAD 26 (15.7%) (vs. no) 1.97 (0.63–6.09) 0.242
CVA 22 (13.3%) (vs. no) 2.83 (0.91–8.79) 0.072
PVD 26 (15.7%) (vs. no) 2.16 (0.70–6.72) 0.183
Malignancy 22 (13.3%) (vs. no) 2.43 (0.78–7.54) 0.124
Comorbidity score 5.19 (0–12) Z6 (vs.o6) 3.12 (1.09–8.99) 0.035
Cause of ESRD (%)
DM 50 (30.1%) 1.43 (0.36–5.73) 0.612
HTN 32 (19.3%) 0.33 (0.04–3.21) 0.343
GN 32 (19.3%) 2.21 (0.55–8.83) 0.263
PKD 8 (4.8%) NS
Renovascular 4 (2.4%) NS
Others 7 (4.2%) NS
Unknown 33 (19.9%) 1 (reference)
Duration of HD (years) 6.2 (0.25–29) Z4.5 (vs.o4.5) 1.14 (0.43–3.07) 0.792
Kidney TPL, yes (%) 8 (4.8%) (vs. no) 3.26 (0.74–14.4) 0.118
Laboratory ﬁndings
Hemoglobin (g/dL) 10.5 (7.6–13.8) Z10 (vs.o10) 1.77 (0.57–5.49) 0.323
Glucose (mg/dL) 128.1 (37–461) Z200 (vs.o200) 1.75 (0.50–6.15) 0.382
Albumin (g/dL) 4.0 (2.7–4.8) Z4 (vs.o4) 0.35 (0.12–1.00) 0.050
BUN (mg/dL) 68.6(30.0–113.6) Z70 (vs.o70) 1.10 (0.41–2.94) 0.857
Mean follow-up (months) 31.2 (1.5–36.9)
Nonrespondents were excluded. Analyzed by unadjusted Cox’s proportional hazard model.
BUN, blood urea nitrogen; CAD, cornary artery disease; CVA, cerebrovascular accident; DM, diabetes mellitus; GN, glomerulonephritis; HD,
hemodialysis; HTN, hypertension; NS, not signiﬁcant; PKD, polycystic kidney disease; PVD, peripheral vascular disease; TPL, transplantation.
Figure 1. Kaplan–Meier survival curve according to depression.
Cumulative survival estimation is assessed in patients according to depres-
sion which was evaluated by Beck’s Depression Inventory (BDI) score.
Patients with a BDI score of 18 or more were deﬁned as a depression group.
Kidney Res Clin Pract 31 (2012) 54–6156duration of HD was 6.275.7 years (range, 0.25–29 years),
and 4.8% of the patients had undergone kidney transplan-
tation previously. Additionally, the age of patients, comor-
bidity score and serum albumin level were signiﬁcantly associated
with mortality at a mean follow-up of 31.2 months (range,
1.5–36.9 months) by unadjusted Cox’s proportional hazard model
(P¼0.021, 0.035 and 0.050, respectively).
The mean BDI score was 14.2579.89 in our patients.
Among the 166 patients, 52 (31.3%) patients had depression
when a BDI score of 18 was deﬁned as a cut-off value, and 114
(68.7%) patients did not. Depression was signiﬁcantly asso-
ciated with old age (61.63712.61 vs. 56.26714.35 years,
P¼0.017) and low Hb level (10.1270.97 vs. 10.7471.24 g/dL,
P¼0.001), compared with patients without depression. How-
ever, male gender (51.9 vs. 64.0%, P¼0.139), comorbidity score
(5.672.8 vs. 5.072.8, P¼0.188), diabetes (34.6% vs. 33.3%,
P¼0.871), mean duration of dialysis (5.675.8 vs. 6.575.7
years, P¼0.378), and serum albumin level (3.9370.34 vs.
4.0070.37 g/dL, P¼0.287) were not different statistically
between two groups. Additionally, the mean PCS, MCS, and
KDCS score were 54.9721.6, 50.7721.0, and 60.8713.2
respectively. Decreased PCS was associated with old age,
female gender, high comorbidity score, diabetes, and lowalbumin level (Po0.05). The factors associated with low MCS
and KDCS score were old age and high comorbidity score
(Po0.05).
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death occurred. The causes of death were ﬁve myocardial
infarction, two pericarditis, ﬁve infection including pneumonia
and cholecystitis, one cancer, and three unknown causes.
Cardiovascular event included myocardial infarction, unstable
angina requiring coronary intervention or bypass graft,
and cardiac arrest. Diabetes foot, pneumonia, tuberculous
pericarditis, cholecystitis, paraspinal abscess, osteomyelitis,
empyema, infected arteriovenous ﬁstula, zoster, and
inﬂuenza were included as infection events in this study. The
complications that required hospitalization were infection,
sepsis, myocardial infarction, unstable angina, completeFigure 2. Kaplan–Meier survival curve according to physical compo-
nent score (PCS). Cumulative survival estimation is assessed in patients
according to the physical component score. Tertiles in physical compo-
nent score: Tertile 1, o45.5; Tertile 2, 45.5–66.5; Tertile 3, 466.5.
Table 2. Mortality Rate and Odds Ratios According to K-BDI and KDQOL
Mortality Univariate analysis Multiva
OR (95% CI) P OR (9
Depression (BDI418) 0.64 (0.21–1.99) 0.441 0.41 (0.
PCSz
Tertile 1 1 (reference) 1 (refe
Tertile 2 0.39 (0.10–1.49) 0.167 0.44 (0.
Tertile 3 0.12 (0.01–1.00) 0.050 0.13 (0.0
MCSy
Tertile 1 1 (reference) 1 (refe
Tertile 2 0.46 (0.12–1.84) 0.273 0.47 (0.
Tertile 3 0.31 (0.06–1.51) 0.146 0.38 (0.
KDCS:
Tertile 1 1 (reference) 1 (refe
Tertile 2 1.10 (0.28–4.40) 0.894 2.04 (0.
Tertile 3 0.79 (0.18–3.53) 0.758 1.24 (0.2
n Model 1: adjusted for age, comorbidity score, and serum albumin.
y Model 2: adjusted for age, comorbidity score, serum albumin, gender, d
economic status.
z PCS: median (55.5), Tertile 1 (o45.5), Tertile 2 (45.5–66.5), Tertile 3 (46
y MCS: median (50.1), Tertile 1 (o39.1), Tertile 2 (39.1–60.3), Tertile 3 (46
: KDCS: median (60.8), Tertile 1 (o53.3), Tertile 2 (53.3–65.9), Tertile 3 (4
BDI, Beck’s Depression Inventory; KDCS, kidney disease component summa
mental component summary score; PCS, physical component summary scoratrioventricular block, stroke, gastric ulcer bleeding, ischemic
colitis, pancreatitis, hepatic encephalopathy, dyspnea, electro-
lyte imbalance, and surgery for gastric cancer or bone fracture
etc. The highest number of hospitalizations was up to ﬁve
times. However, admission for percutaneous transluminal
angioplasty for stenosis of arteriovenous ﬁstula was excluded.
Inﬂuence of depression and HRQOL on all-cause mortality
The 3-year cumulative survival rate was 88.8%, and the
depression did not affect the patients’ survival (depression vs.
nondepression: 91.8% vs. 87.2%, P¼0.437 by log rank test)
(Fig. 1). This trend remained consistent after multivariate
adjustment by both Model 1 and Model 2. Univariate
analysis showed that groups with upper tertiles in PCS were
correlated with less mortality (OR, 0.12; 95% CI, 0.01 to 1.00;
P¼0.05) than lower tertiles (Fig. 2). In Cox’s proportional
hazards models by multivariate adjustment, there was some
evidence of a trend that upper tertiles in PCS were correlated
with less mortality ratios than lower tertiles, but this
was not statistically signiﬁcant. But, upper tertiles in MCS
and KDCS were not correlated with higher survival rates than
lower tertiles in both univariate and multivariate analysis
(Table 2).
Inﬂuence of depression and HRQOL on morbidity
The relationship of depression and HRQOL with enrolled
patients’ morbidity including cardiovascular events, infection,
and complications that required hospitalization was evaluated.
The depression did not affect any of the patients’ morbidity
among cardiovascular events, infection, and admission in both
univariate and multivariate analysis (Tables 3–5). But, upper
tertiles in PCS were correlated with fewer cardiovascular-SF
riate analysis Model 1n Multivariate analysis Model 2y
5% CI) P OR (95% CI) P
13–1.32) 0.134 0.32 (0.08–1.41) 0.134
rence) 1 (reference)
10–1.93) 0.274 0.41 (0.09–1.92) 0.255
1–1.25) 0.077 0.11 (0.01–10.9) 0.060
rence) 1 (reference)
12–1.95) 0.301 0.35 (0.07–1.75) 0.199
07–1.96) 0.246 0.34 (0.06–2.00) 0.232
rence) 1 (reference)
46–8.97) 0.348 1.84 (0.33–10.4) 0.490
4–6.48) 0.798 1.18 (0.19–7.19) 0.861
uration of hemodialysis, hemoglobin, glucose, marriage, religion, and
6.5).
0.3).
65.9).
ry score; KDQOL-SF, Kidney Dialysis Quality of Life—Short Form; MCS,
e.
Table 3. Cardiovascular Event Rate and Odds Ratios According to K-BDI and KDQOL-SF
Cardiovascular event Univariate analysis Multivariate analysis Model 1n Multivariate analysis Model 2y
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Depression (BDI418) 1.46 (0.53–4.00) 0.466 1.30 (0.44–3.85) 0.633 1.99 (0.47–8.38) 0.348
PCSz
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 0.52 (0.16–1.67) 0.272 0.57 (0.14–2.31) 0.428 0.39 (0.08–1.81) 0.229
Tertile 3 0.09 (0.01–0.72) 0.024 0.08 (0.01–0.87) 0.038 0.05 (0.00–0.62) 0.020
MCSy
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 0.57 (0.17–1.88) 0.358 0.61 (0.16–2.37) 0.473 0.64 (0.14–2.87) 0.556
Tertile 3 0.22 (0.04–1.07) 0.060 0.26 (0.05–1.45) 0.124 0.15 (0.02–1.10) 0.062
KDCS:
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 0.70 (0.21–2.36) 0.564 1.00 (0.25–4.01) 0.998 0.92 (0.21–4.13) 0.916
Tertile 3 0.39 (0.10–1.62) 0.195 0.72 (0.15–3.51) 0.686 0.51 (0.09–2.88) 0.444
n Model 1: adjusted for age, comorbidity score, and serum albumin.
y Model 2: adjusted for age, comorbidity score, serum albumin, gender, duration of hemodialysis, hemoglobin, glucose, marriage, religion, and
economic status.
z PCS: median (55.5), Tertile 1 (o45.5), Tertile 2 (45.5–66.5), Tertile 3 (466.5).
y MCS: median (50.1), Tertile 1 (o39.1), Tertile 2 (39.1–60.3), Tertile 3 (460.3).
: KDCS: median (60.8), Tertile 1 (o53.3), Tertile 2 (53.3–65.9), Tertile 3 (465.9).
BDI, Beck’s Depression Inventory; KDCS, kidney disease component summary score; KDQOL-SF, Kidney Dialysis Quality of Life—Short Form; MCS,
mental component summary score; PCS, physical component summary score.
Table 4. Infection Rate and Odds Ratios According to K-BDI And KDQOL-SF
Infection Univariate analysis Multivariate analysis Model 1n Multivariate analysis Model 2y
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Depression (BDI418) 0.86 (0.35–2.09) 0.731 0.80 (0.31–2.03) 0.634 0.55 (0.15–2.03) 0.372
PCSz
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 1.20 (0.40–3.59) 0.748 2.87 (0.78–10.6) 0.113 3.25 (0.71–14.9) 0.131
Tertile 3 0.79 (0.25–2.52) 0.685 1.78 (0.46–6.82) 0.402 1.52 (0.31–7.45) 0.605
MCSy
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 1.17 (0.36–3.74) 0.796 2.05 (0.56–7.50) 0.276 3.62 (0.77–16.9) 0.103
Tertile 3 1.36 (0.44–4.25) 0.593 2.31 (0.65–8.17) 0.195 2.29 (0.51–10.3) 0.280
KDCS:
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 0.26 (0.07–1.02) 0.053 0.31 (0.07–1.32) 0.114 0.20 (0.03–1.27) 0.088
Tertile 3 0.76 (0.28–2.12) 0.605 0.87 (0.27–2.83) 0.822 0.82 (0.20–3.43) 0.788
n Model 1: adjusted for age, comorbidity score, and serum albumin.
y Model 2: adjusted for age, comorbidity score, serum albumin, gender, duration of hemodialysis, hemoglobin, glucose, marriage, religion, and
economic status.
z PCS: median (55.5), Tertile 1 (o45.5), Tertile 2 (45.5–66.5), Tertile 3 (466.5).
y MCS: median (50.1), Tertile 1 (o39.1), Tertile 2 (39.1–60.3), Tertile 3 (460.3).
: KDCS: median (60.8), Tertile 1 (o53.3), Tertile 2 (53.3–65.9), Tertile 3 (465.9).
BDI, Beck’s Depression Inventory; KDCS, kidney disease component summary score; KDQOL-SF, Kidney Dialysis Quality of Life—Short Form; MCS,
mental component summary score; PCS, physical component summary score.
Kidney Res Clin Pract 31 (2012) 54–6158events (OR, 0.09; 95% CI, 0.01 to 0.72; P¼0.024) than lower
tertiles. Even after adjusting for multiple variable including
age, comorbidity index, and albumin, upper tertiles in PCS
were correlated with fewer cardiovascular events than
lower tertiles (OR, 0.08; 95% CI, 0.01 to 0.87; P¼0.038).
There was some evidence of a trend that upper tertiles in
MCS and KDCS were correlated with fewer cardiovascular
events than lower tertiles, but this was not statistically
signiﬁcant in both univariate and multivariate analysis
(Table 3).The depression and any component summary score of KDQOL
did not affect infection rate in our study in both univariate and
multivariate analysis (Table 4). However, the upper tertiles and
middle tertiles in KDCS were associated with less hospitalization
than lower tertiles (OR, 0.38; 95% CI, 0.16 to 0.88; P¼0.024 vs.
OR, 0.39; 95% CI, 0.17 to 0.91; P¼0.029, respectively) in unad-
justed analysis. However, there were no statistical signiﬁcance
after adjusting for multivariate analysis in both Model 1 and 2. In
addition, PCS and MCS were not correlated with admission rate
in both univariate and multivariate analysis (Table 5).
Table 5. Admission Rate and Odds Ratios According to K-BDI and KDQOL-SF
Admission Univariate analysis Multivariate analysis Model 1n Multivariate analysis Model 2y
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Depression (BDI418) 1.06 (0.53–2.11) 0.871 0.90 (0.43–1.88) 0.783 0.95 (0.39–2.34) 0.913
PCSz
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 0.50 (0.22–1.17) 0.109 0.82 (0.32–2.09) 0.680 0.77 (0.28–2.12) 0.611
Tertile 3 0.45 (0.20–1.05) 0.064 0.82 (0.32–2.09) 0.670 0.61 (0.21–1.76) 0.360
MCSy
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 0.48 (0.21–1.10) 0.083 0.63 (0.26–1.53) 0.308 0.76 (0.29–1.99) 0.577
Tertile 3 0.48 (0.21–1.10) 0.083 0.65 (0.27–1.59) 0.343 0.57 (0.21–1.54) 0.266
KDCS:
Tertile 1 1 (reference) 1 (reference) 1 (reference)
Tertile 2 0.39 (0.17–0.91) 0.029 0.56 (0.22–1.40) 0.217 0.51 (0.18–1.47) 0.215
Tertile 3 0.38 (0.16–0.88) 0.024 0.56 (0.22–1.43) 0.225 0.59 (0.21–1.70) 0.331
n Model 1: adjusted for age, comorbidity score and serum albumin.
y Model 2: adjusted for age, comorbidity score, serum albumin, gender, duration of hemodialysis, hemoglobin, glucose, marriage, religion and
economic status.
z PCS: median (55.5), Tertile 1 (o45.5), Tertile 2 (45.5–66.5), Tertile 3 (466.5).
y MCS: median (50.1), Tertile 1 (o39.1), Tertile 2 (39.1–60.3), Tertile 3 (460.3).
: KDCS: median (60.8), Tertile 1 (o53.3), Tertile 2 (53.3–65.9), Tertile 3 (465.9).
BDI, Beck’s Depression Inventory; KDCS, kidney disease component summary score; KDQOL-SF, Kidney Dialysis Quality of Life—Short Form; MCS,
mental component summary score; PCS, physical component summary score.
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In the current study, we evaluated the effect of depression
and HRQOL on patients’ prognosis through mortality
and morbidity among our maintenance HD patients. To our
knowledge, this is the ﬁrst report to reveal the effect of
depression and HRQOL on HD patients’ mortality and morbid-
ity in Korea. Nephrologists have focused on not only traditional
risk factors (e.g., diabetes mellitus, atherosclerosis and
smoking), but also novel risk factors (e.g., epigenetic
change, inﬂammation and oxidative stress) when evaluating
mortality in CKD patients [10]. It is necessary to assess
nontraditional risk factors, because an aging society
encounters a wide variety of comorbidities. Depression is the
most common psychological problem among ESRD patients
[1], and has been shown to be related to mortality in
patients hospitalized with medical illnesses [11] and myocar-
dial infarction [12]. Also, HRQOL containing physical and
mental health is realized to be an important predictive factor
of mortality in ESRD patients [13]. However, clinicians have
little concern for the importance of the role of depression
and HRQOL.
In previous studies, the negative effect of depression, which
was measured at commencement, on patients’ survival has
been often found. HD patients who showed less psychopatho-
logic sign in initial investigations had improved prognosis [14].
And low depression score, young age, and high serum albumin
level were related to better patient survival [15]. Likewise,
some studies revealed that the BDI score and age were the
signiﬁcant predictive factors of mortality in ESRD patients [16].
However, previous studies usually did not fully control the
confounding variables, such as comorbidity, nutrition, and
dialytic interventional effects. In our analysis of maintenance
HD patients, using a 31.2-month average follow-up period, wewere unable to reveal the relationship of depression at base-
line with patients’ mortality and morbidity, when age, comor-
bidity score, and serum albumin concentration were adjusted
as control variables. Similarly, other studies, which had rela-
tively long-term follow-up periods, various psychosocial and
medical information, and well-organized survival analyses,
showed that depression at baseline was not associated with
patients’ mortality [17–19].
However, the time-varying analyses for impact of depres-
sion on mortality in HD patients demonstrated that the
multiple measurement of depression was associated with
mortality signiﬁcantly in both univariate and multivariate
analyses [2]. Multiple measurement of depression contributes
a more realistic model than a single assessment of depression
as a baseline value because time-varying covariate analyses
yield uniﬁed and longitudinal evaluation of changes in depres-
sion over time. In addition, to analyze time-varying levels of
depression at various points permits evaluating both ﬁxed
levels and dynamic changes in depression. Recently, depres-
sion is thought to be linked to malnutrition, inﬂammation or
atherosclerosis in dialysis patients [20]. Thus, multiple mea-
surement of depression could reﬂect dynamic changes of these
factors better than a single assessment. Therefore, our results
that whether the HD patients had depression or not was not
signiﬁcantly associated with patients’ mortality in cross-
sectional survey which evaluated only baseline level of depres-
sion were consistent with previous studies.
In the current study, 31.3% patients were found to have
depression when a BDI score of 18 was deﬁned as a cut-off
value. Koo et al [21] suggested a BDI score of 21 as a cut-off
value to deﬁne depression for Korean HD patients in
their previous study. However, this result was based on
small number of patients (n¼62). On the contrary, a cut-
off value of 16 for BDI score in elderly patients (age460
Kidney Res Clin Pract 31 (2012) 54–6160years) was suggested by Jo et al [22] in their study of 2729
subjects in Korea. In order to avoid false-negatives, we con-
sidered it was reasonable to set 18 instead of 21 as a cut-off
value, because the average age of our HD patients was 57.9
years. Moreover, we also analyzed the relationship between
depression and mortality when 16 or 21 were deﬁned as a cut-
off value. Neither values affected the association between
depression and patients’ survival.
In the current study, PCS was correlated with mortality and
cardiovascular events, and KDCS was associated with hospita-
lization. These results were consistent with previous reports.
The importance of HRQOL in ESRD patients is well known. The
study that measured the SF36 score in 1000 patients who
underwent maintenance HD revealed that a low PCS was
correlated with increased mortality and admission rates [23].
Another study of SF36 score in 65 ESRD patients found that
HRQOL had a strong association with mortality and hospitali-
zation [13]. Several hypotheses have been suggested to
demonstrate the correlation between HRQOL and clinical
prognosis. For instance, a discouraging self-evaluation of
health status could activate a psychoneuroimmunologic reac-
tion and interfere with taking health-protective behavior [24].
Some studies have shown that HRQOL was associated
with nutritional factors, such as cholesterol, serum albumin,
and hemoglobin levels and might conduct to poor
clinical prognosis [13,25]. But, the reason that subjective
evaluation of health status after adjusting for chemical marker
is associated with objective clinical outcome is not entirely
interpreted.
Our study did not necessarily demonstrate a cause-and-
effect relationship. Possibly, a medically worsening condition
leads to a lower level of HRQOL and greater depressive affect in
ESRD patients, subsequently resulting in death. The causality
can only be identiﬁed in an analysis using interventional
clinical trials. Many studies showed that nutritional markers
including albumin, body mass index, and creatinine are strong
predictive factors of HRQOL in ESRD patients [13,26]. And
depression could predict serum albumin concentration
changes in ESRD patients in a study using a time-dependent
approach [27]. Such data suggest possible mechanisms for
mediating the deleterious effect of HRQOL and depression on
patient prognosis. In other words, altered nutrition and
immune system which were affected by HRQOL and depres-
sion could inﬂuence clinical outcome, as hypothesized in
previous study [28]. Additionally, HRQOL and depression
might be an indicator for unmeasured risk factors for mortal-
ity, for instance, maladaptive behaviors for unhealthy status
[10,11]. Further research is warranted to investigate the
mechanisms that may be responsible for the relationship
between HRQOL or depression and clinical outcome.
The current study has some limitations. First, the
current study may be prone to selection bias, which is
an inherent restriction of cohort studies. Because the
patients in three university teaching hospitals and three
local dialysis clinics in Seoul were included in this study,
the population was conﬁned to urban elderly Asian
individuals. Therefore, our ﬁndings should be retested inHD programs in more varied ethnic and regional populations.
Moreover, other selection bias is likely to be present because
we excluded the patients who refused to enroll in this study or
who were diagnosed with dementia. These patients might be
more likely to have depression, lower HRQOL, and poor
prognosis. Therefore, it is possible that our study could under-
estimate the inﬂuence of the depression and HRQOL on the
prognosis. Second, we did not have information about choles-
terol level, body mass index (BMI), and C-reactive protein that
may serve as confounding factors. Third, HRQOL was also
measured only once at the start of the present prospective
study; therefore, our results do not show changes of HRQOL
during the follow-up period. Fourth, interventions including
psychological counseling and antidepressant medication dur-
ing the study period were not evaluated in this study. The
psychological intervention may inﬂuence the results. Finally,
the relatively short-term follow-up period (mean 31.2
months), high survival rate (3-year cumulative survival rate:
88.8%) and small sample size (n¼166) in this study may affect
the result that depression was not a signiﬁcant risk factor for
mortality. Therefore, studies of long duration of follow-up and
large number of patients should be needed. In the current
study, data of total 35 patients were censored because of
kidney transplantation (n¼12), transfer to other hospitals
(n¼21), and follow-up loss of unknown cause (n¼2). This
censored data might affect the result of this study.
In conclusion, the cross-sectional survey of whether the HD
patients had depression was not signiﬁcantly associated with
mortality and morbidity at a mean follow-up of 3 years.
Among the each scale of KDQOL-SF, HRQOL was correlated
with mortality, cardiovascular events, and hospitalization in
univariate analysis. However, in multivariate analysis adjusted
for other prognostic factors, only PCS was associated with
cardiovascular event morbidity. Therefore, high-risk patients
should be monitored more carefully and be invited to psycho-
pharmacological therapy, and it might enhance patients’
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